Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned
- PMID: 33890391
- DOI: 10.1002/pbc.29068
Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned
Abstract
Background: Early diagnosis of sickle cell disease (SCD) through newborn screening (NBS) is a cost-effective intervention, which reduces morbidity and mortality. In sub-Saharan Africa (SSA) where disease burden is greatest, there are no universal NBS programs and few institutions have the capacity to conduct NBS. We determined the feasibility and challenges of implementing NBS for SCD in Ghana's largest public hospital.
Procedure: The SCD NBS program at Korle Bu Teaching Hospital (KBTH) is a multiyear partnership between the hospital and the SickKids Center for Global Child Health, Toronto, being implemented in phases. The 13-month demonstration phase (June 2017-July 2018) and phase one (November 2018-December 2019) focused on staff training and the feasibility of universal screening of babies born in KBTH.
Results: During the demonstration phase, 115 public health nurses and midwives acquired competency in heel stick for dried blood spot sampling. Out of 9990 newborns, 4427 babies (44.3%) were screened, of which 79 (1.8%) were identified with presumptive SCD (P-SCD). Major challenges identified included inadequate nursing staff to perform screening, shortage of screening supplies, and delays in receiving screening results. Strategies to overcome some of the challenges were incorporated into phase one, resulting in increased screening coverage to 83.7%.
Conclusions: Implementing NBS for SCD in KBTH presented challenges with implications on achieving and sustaining universal NBS in KBTH and other settings in SSA. Specific steps addressing these challenges comprehensively will help build on the modest initial gains, moving closer toward a sustainable national NBS program.
Keywords: Ghana; Korle Bu; newborn; screening; sickle cell disease.
© 2021 Wiley Periodicals LLC.
Similar articles
-
Newborn screening initiatives for sickle cell disease in Africa.Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):227-233. doi: 10.1182/hematology.2024000548. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644044 Free PMC article. Review.
-
Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.Int Health. 2019 Nov 13;11(6):589-595. doi: 10.1093/inthealth/ihz028. Int Health. 2019. PMID: 31145786 Free PMC article.
-
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.Pediatr Blood Cancer. 2019 May;66(5):e27657. doi: 10.1002/pbc.27657. Epub 2019 Feb 5. Pediatr Blood Cancer. 2019. PMID: 30724025
-
Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.Pharmacotherapy. 2023 May;43(5):430-441. doi: 10.1002/phar.2792. Epub 2023 Mar 26. Pharmacotherapy. 2023. PMID: 36906823 Review.
-
Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti.Blood Adv. 2024 Jan 9;8(1):14-22. doi: 10.1182/bloodadvances.2023010104. Blood Adv. 2024. PMID: 37820110 Free PMC article.
Cited by
-
Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa.Semin Hematol. 2023 Sep;60(4):192-199. doi: 10.1053/j.seminhematol.2023.08.002. Epub 2023 Aug 24. Semin Hematol. 2023. PMID: 37730472 Free PMC article.
-
Newborn screening initiatives for sickle cell disease in Africa.Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):227-233. doi: 10.1182/hematology.2024000548. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644044 Free PMC article. Review.
-
A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea.Blood. 2025 Jul 3;146(1):13-28. doi: 10.1182/blood.2024028136. Blood. 2025. PMID: 40324066 Free PMC article.
-
A Novel Newborn Screening Program for Sickle Cell Disease in Nigeria.Int J Neonatal Screen. 2024 Sep 30;10(4):67. doi: 10.3390/ijns10040067. Int J Neonatal Screen. 2024. PMID: 39449355 Free PMC article.
-
Analysis of clinical presentation, hematological factors, self-reported bed net usage, and malaria burden in sickle cell disease patients.EClinicalMedicine. 2021 Jul 31;39:101045. doi: 10.1016/j.eclinm.2021.101045. eCollection 2021 Sep. EClinicalMedicine. 2021. PMID: 34386757 Free PMC article.
References
REFERENCES
-
- Weatherall DJ. The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol. 2011;154(6):736-744.
-
- WHO. Sickle-Cell Anaemia. Provisional Agenda Item 11.4. In: 59th World Health Assembly, April 24, 2006. https://apps.who.int/gb/archive/pdf_files/wha59/a59_9-en.pdf. Accessed April 22, 2020.
-
- Wastnedge E, Waters D, Patel S, et al. The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis. J Glob Health. 2018;8(2):021103.
-
- Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011;41(6):S398-S405.
-
- Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. N Engl J Med. 1986;314(25):1593-1599.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous